Paratek

is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of infectious diseases...
Read more
Paratek CEO: Evan Loh

CEO

Evan Loh

CEO Approval Rating

90/100

1996

PublicAcquired by Novo Holdings A/SNASDAQPRTK

2834 NAICS listing
Annual Revenue
$177M
Employees
210
Funding
$193M
Acquisitions
1

Paratek Competitors

1Melinta
2Cumberland Pharmaceuticals
3Nabriva
4Spero Therapeutics
5Tetraphase
6Moderna
7Achillion Pharmaceuticals Inc
8BioCryst
9Achaogen
10CureVac
See 35+ competitors

Trending Companies